Bank of America
CCEL icon

Bank of America’s Cryo-Cell International CCEL Stock Holding History

Bank of America’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3
Closed -$10 – 5899
2025
Q4 		$10 Hold
3
– – ﹤0.01% 7197
2025
Q3 		$14 Sell
3
-34
-92% -$161 ﹤0.01% 8195
2025
Q2 		$192 Buy
37
+3
+9% +$16 ﹤0.01% 7848
2025
Q1 		$217 Buy
34
+1
+3% +$7 ﹤0.01% 7669
2024
Q4 		$245 Hold
33
– – ﹤0.01% 7550
2024
Q3 		$210 Sell
33
-24
-42% -$165 ﹤0.01% 7555
2024
Q2 		$433 Buy
+57
New +$472 ﹤0.01% 7383
2024
Q1 		– Sell
-2
Closed -$12 – 7769
2023
Q4 		$12 Buy
+2
New +$10 ﹤0.01% 7747
2023
Q1 		– Sell
-4
Closed -$17 – 7839
2022
Q4 		$17 Sell
4
-996
-100% -$4.77K ﹤0.01% 8009
2022
Q3 		$6K Hold
1,000
– – ﹤0.01% 7336
2022
Q2 		$6K Sell
1,000
-5,000
-83% -$32K ﹤0.01% 7540
2022
Q1 		$46K Hold
6,000
– – ﹤0.01% 7205
2021
Q4 		$70K Buy
6,000
+5,000
+500% +$62.3K ﹤0.01% 7056
2021
Q3 		$12K Buy
+1,000
New +$12.3K ﹤0.01% 7521

Other funds holding CCEL

SA
SFI Advisors Montclair, New Jersey $116M AUM 37.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's CCEL Position: Q1 2026 in Review

Bank of America sold out of Cryo-Cell International (CCEL) in Q1 2026, closing a stake of 3 shares — an estimated $10 sold.

Bank of America first reported a position in CCEL in Q3 2021 and held it in 14 quarters. The position peaked at $70K in Q4 2021. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

  • Bank of America reported no remaining Cryo-Cell International position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 3 Cryo-Cell International shares in Q1 2026, an estimated $10.
  • Bank of America first reported a position in Cryo-Cell International in Q3 2021 and held it in 14 quarters.
  • Bank of America's Cryo-Cell International position peaked at $70K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.